ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,347, issued on May 26.
"Recombinant interferon with changed spatial configuration" was invented by Guangwen Wei (Chengdu, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating tumors in subjects by using a recombinant interferon (rSIFN-co), and optionally, methods for treating solid tumors, such as lung cancer, among others, with or without prior surgery, and as a first line or second line monotherapy or in combination with one or more other anti-tumor therapies. The present invention further provides non-surgical methods for eliminating tumors or reducing tumor sizes in subjects, and/or preventing p...